/Investor DB

Spectrum Equity — 2021 Investments

5 investments dated 2021 · listed companies and verified rows first · show all

Membersymembersy.comSep 2021 · $66M

Clerri is a dental membership platform that lets DSOs and independent dental practices create and run their own recurring membership plans, integrating with practice management software so staff can surface membership opportunities, show patient savings, and enroll patients directly.

Digital HealthHealthtechSaaS

OTA Insightotainsight.comNov 2021 · $80M

Lighthouse (Ota Insight) operates a commercial platform for hoteliers that aggregates market rate, demand, and parity data and applies AI to support pricing, demand forecasting, performance benchmarking, and direct bookings.

AI & Machine LearningSaaSTravel & Hospitality

Co-investorsLoric VenturesEight Roads VenturesF-Prime Capital

otter aiotter.aiin𝕏Feb 2021

Otter.ai is an AI-powered meeting assistant that records, transcribes, and summarizes conversations in real time across multiple languages, automatically capturing decisions and action items.

AI & Machine LearningFuture of WorkSaaSMountain View, US

Sam Liang(Founder)inEli M(Founder)inYun Fu(Founder)

Co-investors500 GlobalAidenlair CapitalDFJ DragonFundDraper DragonDuke Capital PartnersFoothill Ventures+13 more

Quantilequantile.cominJan 2021 · $51Macquired by London Stock Exchange

Quantile provides portfolio compression and optimisation services that use algorithms to reduce risk, notional, margin and capital requirements for financial institutions.

Enterprise SoftwareFintech

Co-investorsCorrelation VenturesFirst Round Capital

Zenworkzenwork.comin𝕏Nov 2021

Zenwork provides cloud-based tax compliance and eFiling solutions for individuals and businesses, including IRS-approved platforms for filing 1099s, W2s, 2290s, FBAR, and tax extensions.

Enterprise SoftwareFintechLegalTechSaaS

Sanjeev K. Singh(Founder)inEdward Pratt, Jr.(Founder)in

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.